{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:16:00Z","timestamp":1793121360162,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liver transplantation (LT) is a primary treatment option for patients with end-stage liver disease. However, post-transplantation immune regulation is critical to graft survival and long-term patient outcomes. Following liver transplantation, the recipient\u2019s immune system mounts a response against the graft, while the graft promotes anti-rejection immune reactions and the establishment of immune tolerance. In recent years, advances in the study of the immune microenvironment have provided new insights into post-transplantation immune regulation. Meanwhile, immunotherapy strategies have opened new possibilities for improving transplantation success rates and long-term survival. This review summarizes recent progress in understanding the immune microenvironment and immunotherapy following liver transplantation, focusing on key components of the transplant immune microenvironment, their regulatory networks and mechanisms, major immunosuppressive strategies, emerging immunotherapeutic approaches, and current challenges. The aim was to provide a theoretical foundation for optimizing clinical practice.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1602877","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:13:29Z","timestamp":1747008809000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Regulation of the immune microenvironment and immunotherapy after liver transplantation"],"prefix":"10.3389","volume":"16","author":[{"given":"Tianyi","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangyou","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2021.11.026","article-title":"Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver","volume":"76","author":"Kadono","year":"2022","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v12.i7.157","article-title":"Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies","volume":"12","author":"Sharma","year":"2022","journal-title":"World J Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2597","article-title":"Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials","volume":"76","author":"Tustumi","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.679398","article-title":"High mobility group box 1 contributes to the acute rejection of liver allografts by activating dendritic cells","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3149426","article-title":"The hyperlipidemia caused by overuse of glucocorticoid after liver transplantation and the immune adjustment strategy","volume":"2017","author":"Meng","year":"2017","journal-title":"J Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001259","article-title":"Long-term, prolonged-release tacrolimus-based immunosuppression in de novo liver transplant recipients: 5-year prospective follow-up of patients in the DIAMOND study","volume":"7","author":"Friman","year":"2021","journal-title":"Transplant Direct"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.535012","article-title":"Clinical and basic research progress on treg-induced immune tolerance in liver transplantation","volume":"12","author":"Ni","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.5","article-title":"Immunological functions of liver sinusoidal endothelial cells","volume":"13","author":"Knolle","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1042\/BST20200696","article-title":"Phagocytic clearance of apoptotic, necrotic, necroptotic and pyroptotic cells","volume":"49","author":"Atkin-Smith","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"B12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/foods11091293","article-title":"Mitigation of DSS-induced colitis potentially via Th1\/Th2 cytokine and immunological function balance induced by phenolic-enriched buckwheat (fagopyrum esculentum moench) bee pollen extract","volume":"11","author":"Chen","year":"2022","journal-title":"Foods"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4854","article-title":"Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma","volume":"12","author":"Xu","year":"2016","journal-title":"Oncol Lett"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1038\/s41467-023-39023-1","article-title":"Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation","volume":"14","author":"Du","year":"2023","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.436","article-title":"Emerging role of B cells in chronic allograft dysfunction","volume":"119","author":"Colvin","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.10.004","article-title":"Prolonged survival effects induced by immature dendritic cells and regulatory T cells in a rat liver transplantation model","volume":"79","author":"He","year":"2016","journal-title":"Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103382","article-title":"IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells","volume":"188","author":"Matta","year":"2012","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12252","article-title":"Effects of IL-10- and FasL-overexpressing dendritic cells on liver transplantation tolerance in a heterotopic liver transplantation rat model","volume":"97","author":"Chen","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of Kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1179077","article-title":"Role of kupffer cells in tolerance induction after liver transplantation","volume":"11","author":"Zheng","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004060","article-title":"Influence of calcineurin inhibitor choice on outcomes in kidney transplant recipients aged \u226560 Y: A collaborative transplant study report","volume":"106","author":"Echterdiek","year":"2022","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: A guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00262.2020","article-title":"Calcineurin inhibitors: a double-edged sword","volume":"320","author":"Ume","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2017.78.5.278","article-title":"Liver transplantation: post-transplant management","volume":"78","author":"Halliday","year":"2017","journal-title":"Br J Hosp Med (Lond)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trre.2015.01.002","article-title":"Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management","volume":"29","author":"Shuker","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/TP.0000000000001806","article-title":"mTOR inhibition role in cellular mechanisms","volume":"102","author":"Zaza","year":"2018","journal-title":"Transplantation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819128","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: Are we making headway","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.711943","article-title":"CYP3A4*22 genotyping in clinical practice: Ready for implementation","volume":"12","author":"Mulder","year":"2021","journal-title":"Front Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.129","article-title":"Functional gene variants of CYP3A4","volume":"96","author":"Werk","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.567715","article-title":"Use of T cell mediated immune functional assays for adjustment of immunosuppressive or anti-infective agents in solid organ transplant recipients: A systematic review","volume":"11","author":"Rezahosseini","year":"2020","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2016.0130","article-title":"Combined detection of serum IL-10, IL-17, and CXCL10 predicts acute rejection following adult liver transplantation","volume":"39","author":"Kim","year":"2016","journal-title":"Mol Cells"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7150\/thno.102671","article-title":"Optical molecular imaging technology and its application in precise surgical navigation of liver cancer","volume":"15","author":"He","year":"2025","journal-title":"Theranostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1602877\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:13:30Z","timestamp":1747008810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1602877\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2025.1602877"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1602877","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"article-number":"1602877"}}